← Back to all media
We talk to SV Health Investors about COVID-19
This week, I was fortunate to catch up with SV Health Investors, managers of the unquoted investments within International Biotechnology Trust. The discussion centred on COVID-19 and how it is affecting the healthcare industry. One UK-based member of the team, Kate Bingham, is a member of the UK Government’s Vaccine Taskforce. The majority of the team is based at the firm’s offices in Boston.
Published on 24th April 2020